Article Versions Notes

Masarone D, Kittleson MM, Martucci ML, Valente F, Gravino R, Verrengia M, Ammendola E, Contaldi C, Di Palma V, Caiazzo A, et al. Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study. Journal of Clinical Medicine. 2022; 11(14):4227. https://doi.org/10.3390/jcm11144227

Masarone, Daniele, Michelle M. Kittleson, Maria L. Martucci, Fabio Valente, Rita Gravino, Marina Verrengia, Ernesto Ammendola, Carla Contaldi, Vito Di Palma, Angelo Caiazzo, and et al. 2022. "Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study" Journal of Clinical Medicine 11, no. 14: 4227. https://doi.org/10.3390/jcm11144227

Masarone, D., Kittleson, M. M., Martucci, M. L., Valente, F., Gravino, R., Verrengia, M., Ammendola, E., Contaldi, C., Di Palma, V., Caiazzo, A., Petraio, A., Pollesello, P., & Pacileo, G. (2022). Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study. Journal of Clinical Medicine, 11(14), 4227. https://doi.org/10.3390/jcm11144227